Supreme Court Upholds VA Court Decision Not to Review 'Benefit-of-the-Doubt' Evidence in Veterans' Claims
The U.S. Supreme Court ruled against two veterans who argued that their disability claims were unfairly denied because they did not receive favorable decisions when the evidence presented in their cases was equal.
In a 7-2 decision, the court ruled that the U.S. Court of Appeals for Veterans Claims is not required to review the Department of Veterans Affairs' application of the "benefit-of-the-doubt" rule in most decisions. The standard requires the VA to approve veterans' claims when the supporting evidence, either for or against approval, is close.
Writing for the majority, Justice Clarence Thomas said the VA claims court and the Federal Circuit Court, which upheld the lower court's decision, weren't legally bound, in the specific cases, to conduct a benefit-of-the-doubt review.
Read Next: Court-Martial Convenes for Pentagon Leaker Already Facing Years Behind Bars
Instead, the claims court was required only to review the cases for any errors by the claims adjudicators or the Board of Veterans Appeals, Thomas wrote in a decision published March 5.
"We hold that the Veterans Court must review the VA's application of the rule the same way it would any other determination -- by reviewing legal issues [from the beginning] and factual issues for clear error," Thomas wrote.
The case, Bufkin v. Collins, included the arguments of two veterans: Joshua Bufkin, who served in the Air Force from 2005 to 2006, and former Army soldier Norman Thornton, who served from 1988 to 1991.
Bufkin filed a disability claim for post-traumatic stress disorder roughly seven years after he left the service. As an airman, he was unable to pass the training needed to become a military policeman, citing marital stress as a contributing factor. According to court records, Bufkin said his wife threatened suicide if he stayed in the military. He ultimately was granted a hardship discharge at his own request.
When he applied for VA health care and benefits, Buffkin said his issues were service-related. VA doctors disagreed over his diagnosis of PTSD as well as his service connection, and his claim was rejected.
Thornton served in the 1990-1991 Persian Gulf War and received a 10% disability rating for PTSD that later was increased to 50%. He appealed the decision, arguing that the rating should have been higher.
In both cases, the Veterans Board of Appeals weighed the evidence, which, in Bufkin's case, conflicted, and in Thornton's case, did not support a higher disability rating, according to the board.
The Veterans Court of Appeals later determined that no errors were made by the claims adjudicators or the board, but it did not conduct a benefit-of-the-doubt review. On appeal, the Federal Circuit Court of Appeals agreed that the review was not necessary.
In their petition to the Supreme Court, the plaintiffs argued that the law clearly indicates that veterans should receive the benefit of the doubt. Thomas said, however, that they failed to make their legal argument, adding that the veterans court can overturn a decision only when there is clear error.
'After closely examining the way in which the VA conducts the approximate balance inquiry [of benefit-of-the-doubt evidence], we conclude it is a predominantly factual question and thus subject to clear-error review,' Thomas wrote.
Justices Ketanji Brown Jackson and Justice Neil Gorsuch disagreed. Jackson, writing a dissenting opinion, said veterans are entitled to have "any reasonable doubt on a material issue" resolved in their favor as, she argued, Congress intended.
"The court today concludes that Congress meant nothing when it inserted [into law,] in response to concerns that the Veterans Court was improperly rubberstamping the VA's benefit-of-the-doubt determinations and also that the Veterans Court is not obliged to do anything more than defer to those agency decisions," Brown wrote. "I respectfully dissent."
In a summary, the justices said they accepted the case to determine whether the Veterans Court was required to consider the VA's use of the benefit-of-the-doubt in claims decisions beyond a review for error.
The majority decided that, in most cases, it wasn't.
"[The law] does not establish a new standard of review for challenges to the VA's application of the benefit-of-the-doubt rule," Thomas wrote.
Related: Supreme Court Weighs Arguments in Lawsuit over Veterans Getting 'Benefit of Doubt' in Claims Decisions

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 hours ago
- Yahoo
Glassbeam Awarded FedRAMP Authorization for its SAAS analytics solution for connected medical systems by the U.S. Department of Veterans Affairs.
This designation enables Glassbeam to support federal government agency customers increase uptime for all MRI and CT scanners and avoid costly service delays. SANTA CLARA, Calif., June 13, 2025 /PRNewswire/ -- Glassbeam, Inc., a pioneer in data and predictive analytics for connected medical machines, today announced it has received FedRAMP authorization. Delivered as a service, Clinsights Service Analytics enables federal agencies, state and local governments, and providers of critical infrastructure to improve equipment availability and service productivity. The Federal Risk and Authorization Management Program (FedRAMP) is a federal government-wide program that provides a standardized approach to security assessment, authorization and continuous monitoring for cloud products and services. FedRAMP authorization follows a successful security audit via an accredited third-party assessor. "Glassbeam considers it a privilege to support the VA in its vital mission to serve Veterans. Achieving FedRAMP authorization for the VA demonstrates our unwavering commitment to the secure and careful handling of critical medical data. We are eager to continue our collaboration, enhancing the healthcare experience for those who have served.," according to Rich Jones, CEO of Glassbeam. Clinsights Service Analytics provides the only multi-vendor SaaS offering for proactive alerts in the federal marketplace, allowing federal organizations improve machine uptime, service engineer productivity and patient care by transforming maintenance services from break-fix to proactive-predictive through a highly scalable platform. Glassbeam recently partnered with the VHA Medical Device Networking and Cybersecurity Division and has supported the U.S. Department of Veterans Affairs with a deployment of Glassbeam Service Analytics within VISN 2. Unexpected equipment failures, lead to unplanned downtime which disrupts patient schedules, additional costs, and reduced access for imaging departments. With the completed authorization, Glassbeam is now listed on the FedRAMP Marketplace and increasing our work with the VA to deliver improved diagnosis and issue resolution. "We are excited to bring forward the technology to enable the monitoring and alerts for our valued customers, the VA clinicians." stated Garth Donaldson, Vice President of Sales, Glassbeam. Glassbeam uses artificial intelligence, predictive analytics, and machine learning to monitor medical devices, including MRI, CT scanners and other imaging equipment, in real-time to anticipate needed repairs and maximize uptime. Its ease of deployment and remote access option ensures operational efficiency while helping patients receive much-needed care, avoiding unnecessary delays. For more information, visit About GlassbeamGlassbeam is a pioneer in predictive analytics for medical devices. Our solutions enable improved uptime, utilization, and productivity by providing actionable insights. Glassbeam's cloud-based platform incorporates proprietary analytics and workflow to achieve tangible outcomes for organizations such as Canon Medical Systems USA, MultiCare Health System, Stanford, Brown's Medical Imaging, and Agiliti Health. For more information, visit Clinsights™ is a trademark of Glassbeam. Press ContactDave View original content to download multimedia: SOURCE Glassbeam, Inc. Sign in to access your portfolio
Yahoo
a day ago
- Yahoo
ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets
Recon Supply Named Exclusive U.S. Distributor of ReShape's STIMEL-03, Lap-Band® 2.0 FLEX, and Full Product Portfolio to Reach U.S. Veterans and Active-Duty Service Members IRVINE, Calif., June 12, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the signing of an exclusive U.S. distribution agreement with Recon Supply. Through this new strategic partnership, Recon Supply will distribute ReShape's cutting-edge portfolio, including the STIMEL-03 neuromuscular rehabilitation device, the next-generation Lap-Band® 2.0 FLEX, and the full range of ReShape products, across the Veterans Administration (VA) and Department of Defense (DoD) healthcare systems. This collaboration will expand access to proven, life-changing treatments for more than 18 million U.S. veterans and active military personnel. 'This agreement with Recon Supply marks a pivotal step forward in ReShape's mission to expand access to innovative medical technologies that improve lives,' stated Paul F. Hickey, President and Chief Executive Officer of ReShape Lifesciences. 'Through Recon's extensive footprint across the VA and DoD healthcare systems, we look forward to bringing our FDA-cleared STIMEL-03 system, a cutting-edge neurorehabilitation platform that is transforming clinical care with real-time EMG biofeedback and personalized electrical stimulation, to veterans and military personnel recovering from stroke, injury, or surgery. Additionally, the Lap-Band® 2.0 FLEX, our next-generation, minimally invasive weight loss solution, offers a safe, adjustable option for individuals struggling with obesity. Together, these technologies reflect our commitment to delivering high-impact, clinically proven solutions to patients in need, including those who have served our country.' 'Partnering with ReShape Lifesciences aligns perfectly with our mission to deliver innovative, life-changing medical solutions to those who have served our country,' added Steve Clark, Chief Executive Officer of Recon Supply and a U.S. Marine Corps veteran. 'With established access to VA and DoD facilities through our Distribution and Pricing Agreement (DAPA), Federal Supply Schedule (FSS), and Electronic Catalog (ECAT) contracts, this agreement allows us to expand the reach of ReShape's most impactful technologies—including the STIMEL-03 rehabilitation system and the Lap-Band® 2.0 FLEX. These solutions are well-suited to the complex needs of the veteran and active-duty populations we serve. Since relaunching in 2022, Recon Supply has grown over 113% year-over-year and now distributes to 102 VA Medical Centers nationwide, with a team made up almost entirely of veterans and veteran spouses. We are proud to partner with ReShape to bring these vital solutions to the men and women who have sacrificed for our country.' About Recon SupplyRecon Supply is a trusted distributor of medical products and technologies, specializing in providing high-quality solutions to federal agencies and healthcare systems. As a Service-Disabled Veteran-Owned Small Business (SDVOSB), Recon Supply is dedicated to delivering the most innovative medical technologies while actively supporting the veteran community through hiring initiatives. With a focus on excellence and reliability, Recon Supply is committed to enhancing patient care through innovative partnerships. For more information on Recon Supply, visit About ReShape Lifesciences® ReShape Lifesciences® is America's premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band® System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The investigational vagal neuromodulation system utilizes a proprietary vagus nerve block and stimulation technology platform for the treatment of type 2 diabetes and metabolic disorders. The Obalon® balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. For more information, please visit Forward-Looking Safe Harbor Statement This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from those discussed due to known and unknown risks, uncertainties, and other factors. These forward-looking statements generally can be identified by the use of words such as "expect," "plan," "anticipate," "could," "may," "intend," "will," "continue," "future," other words of similar meaning and the use of future dates. Forward-looking statements in this press release include statements about the expectations regarding the distribution arrangement of Recon Supply. These and additional risks and uncertainties are described more fully in the company's filings with the Securities and Exchange Commission, including those factors identified as "risk factors" in our most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. We are providing this information as of the date of this press release and do not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise, except as required by law. CONTACTSReShape Lifesciences Investor Contact:Paul F. HickeyPresident and Chief Executive Officer949-276-7223ir@ Investor Relations Contact:Rx Communications GroupMichael Miller(917)-633-6086mmiller@ Errore nel recupero dei dati Effettua l'accesso per consultare il tuo portafoglio Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati


Newsweek
a day ago
- Newsweek
VA Announces $42-Million Boost To Veterans
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The Department of Veterans Affairs (VA) announced on Wednesday that it will provide approximately $42 million in federal grants to eligible nonprofit and community-based organizations helping veterans facing or at risk of homelessness. These grants, which are being made available through the VA's Legal Services for Veterans Grant Program, would assist people with various legal services as they transition out of homelessness or fight to keep a roof over their heads. Why It Matters Last year, as many as 32,882 veterans were experiencing homelessness in the U.S., according to VA data. That is about 5 percent of the entire U.S. homeless population, showing that veterans are significantly overrepresented compared to other categories. A combination of factors, including the ongoing housing shortage and affordability crisis in the U.S., the difficulties in transition from active duty to civilian life, common mental health issues, substance use disorders, post-traumatic stress disorders, injuries and disabilities, contribute to putting the veteran population particularly at risk of facing homelessness. Army veteran Doug Cohen attends a Stand Down event designed to help veterans who are homeless or housing insecure on June 16, 2023, in Chicago. Army veteran Doug Cohen attends a Stand Down event designed to help veterans who are homeless or housing insecure on June 16, 2023, in the number of veterans experiencing homelessness has decreased consistently over the past decade, partially thanks to the VA's efforts to fund mental-health programs and give them housing assistance, the work of nonprofit and community-based organizations remains crucial to help keep veterans housed. What To Know Eligible organizations hoping to receive the VA's funding can apply for grants worth up to $500,000. The amount received is meant to fund the organization's operations for a two-year period beginning October 1, 2025, through September 30, 2027. The funds are to help provide veterans with representation in landlord-tenant disputes to prevent evictions; assisting them with court proceedings for child support, custody or estate planning; helping them obtain benefits like disability compensation; and offering them defense in criminal cases that can prolonged or increase their risk of homelessness, including outstanding warrants, fines and driver's license revocation. The VA has announced several major funding efforts in recent months, including a $52.5-million initiative to prevent veteran suicides through community-based grants. The focus on legal services in the current $42 million grant expands the department's support for housing stability and social services for veterans. What People Are Saying VA secretary Doug Collins said in a press release on Wednesday: "Services to help veterans obtain benefits, maintain access to housing and navigate other common legal issues can make a huge difference in preventing or resolving homelessness. "These important grants will help us make a positive difference in the lives of thousands of veterans." What Happens Next Eligible organizations have until 4 p.m. ET on July 7 to apply for the grants. The VA will review applications and distribute funds to qualified organizations ahead of the program's start date of October 1, 2025. If you are a veteran facing or at risk of homelessness, we would like to hear from you. Please email me at